INBS
Price
$1.23
Change
-$0.15 (-10.87%)
Updated
Dec 18, 04:19 PM (EDT)
WILLF
Price
$36.24
Change
-$0.12 (-0.33%)
Updated
Nov 21 closing price
Ad is loading...

INBS vs WILLF

Header iconINBS vs WILLF Comparison
Open Charts INBS vs WILLFBanner chart's image
Intelligent Bio Solutions
Price$1.23
Change-$0.15 (-10.87%)
Volume$1.2K
CapitalizationN/A
Demant AS
Price$36.24
Change-$0.12 (-0.33%)
Volume$840
CapitalizationN/A
INBS vs WILLF Comparison Chart
Loading...
INBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WILLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INBS vs. WILLF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBS is a Hold and WILLF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (INBS: $1.38 vs. WILLF: $36.24)
Brand notoriety: INBS and WILLF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INBS: 160% vs. WILLF: 169%
Market capitalization -- INBS: $11.55M vs. WILLF: $8.95B
INBS [@Medical Specialties] is valued at $11.55M. WILLF’s [@Medical Specialties] market capitalization is $8.95B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBS’s FA Score shows that 1 FA rating(s) are green whileWILLF’s FA Score has 0 green FA rating(s).

  • INBS’s FA Score: 1 green, 4 red.
  • WILLF’s FA Score: 0 green, 5 red.
According to our system of comparison, INBS is a better buy in the long-term than WILLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBS’s TA Score shows that 4 TA indicator(s) are bullish while WILLF’s TA Score has 2 bullish TA indicator(s).

  • INBS’s TA Score: 4 bullish, 5 bearish.
  • WILLF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, WILLF is a better buy in the short-term than INBS.

Price Growth

INBS (@Medical Specialties) experienced а -16.08% price change this week, while WILLF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.04%. For the same industry, the average monthly price growth was +4.06%, and the average quarterly price growth was +1.95%.

Reported Earning Dates

INBS is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Medical Specialties (-2.04% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WILLF($8.95B) has a higher market cap than INBS($11.5M). WILLF has higher P/E ratio than INBS: WILLF (25.84) vs INBS (0.06). WILLF YTD gains are higher at: -17.636 vs. INBS (-65.850). WILLF has higher annual earnings (EBITDA): 4.3B vs. INBS (-12.05M). WILLF has more cash in the bank: 1.13B vs. INBS (1.12M). INBS has less debt than WILLF: INBS (1.08M) vs WILLF (15.1B). WILLF has higher revenues than INBS: WILLF (19.7B) vs INBS (2.46M).
INBSWILLFINBS / WILLF
Capitalization11.5M8.95B0%
EBITDA-12.05M4.3B-0%
Gain YTD-65.850-17.636373%
P/E Ratio0.0625.840%
Revenue2.46M19.7B0%
Total Cash1.12M1.13B0%
Total Debt1.08M15.1B0%
FUNDAMENTALS RATINGS
WILLF: Fundamental Ratings
WILLF
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INBSWILLF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
51%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
36%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
39%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
33%
View a ticker or compare two or three
Ad is loading...
INBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WILLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INGN9.120.17
+1.90%
Inogen
CLRB0.26N/A
+1.82%
Cellectar Biosciences
RPD39.04-0.21
-0.54%
Rapid7
ABL7.70-0.16
-2.04%
Abacus Life
MRNA40.76-1.08
-2.58%
Moderna

INBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBS has been loosely correlated with IINN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if INBS jumps, then IINN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBS
1D Price
Change %
INBS100%
-7.07%
IINN - INBS
35%
Loosely correlated
-4.46%
WILLF - INBS
27%
Poorly correlated
N/A
PRPO - INBS
24%
Poorly correlated
-2.80%
BNGO - INBS
24%
Poorly correlated
-6.01%
NNOX - INBS
24%
Poorly correlated
-0.68%
More

WILLF and

Correlation & Price change

A.I.dvisor tells us that WILLF and INBS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WILLF and INBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WILLF
1D Price
Change %
WILLF100%
N/A
INBS - WILLF
26%
Poorly correlated
-7.07%
CLPBY - WILLF
24%
Poorly correlated
-1.90%
ATR - WILLF
23%
Poorly correlated
-2.71%
CLPBF - WILLF
22%
Poorly correlated
N/A
WILYY - WILLF
9%
Poorly correlated
-2.93%
More